Cuppens, Kristof http://orcid.org/0000-0002-8153-0008
,
Lodewyckx, Liesbet http://orcid.org/0000-0003-0899-6992
Demedts, Ingel http://orcid.org/0000-0002-2949-8821
Decoster, Lore http://orcid.org/0000-0001-7563-0179
Colinet, Benoît http://orcid.org/0000-0001-6673-9017
Deschepper, Koen http://orcid.org/0000-0002-1176-0510
Janssens, Annelies http://orcid.org/0000-0002-1464-163X
Galdermans, Daniella http://orcid.org/0000-0002-2771-1561
Pieters, Thierry http://orcid.org/0000-0003-4438-3026
Funding for this research was provided by:
AstraZeneca
Article History
Accepted: 6 March 2021
First Online: 12 March 2021
Declarations
:
: AstraZeneca funded the study and was involved in all stages of the research, including the study design, the collection, analysis and interpretation of data, the writing of the article and the decision to submit the article for publication. AstraZeneca also paid for medical writing support.
: L. Lodewyckx is an employee of AstraZeneca. All other authors and/or their institutions received study fees and/or non-financial support from AstraZeneca during the conduct of the study and for advisory boards. In addition, outside the submitted work, K. Cuppens received personal fees and non-financial support from Bristol-Myers-Squibb, Hoffman-La Roche, Merck-Sharp-Dohme, Pfizer and Boehringer-Ingelheim and personal fees from Merck-Serono; I. Demedts received a grant and personal fees from AstraZeneca; L. Decoster received travel grants from Hoffman-La Roche, Merck-Sharp-Dohme and a study grant from Boehringer-Ingelheim; K. Deschepper received personal fees from AstraZeneca, Hoffman-La Roche, Merck-Sharp-Dohme, Boehringer-Ingelheim and Bristol-Myers-Squibb; D. Galdermans received personal fees from Hoffman-La Roche, Merck-Sharp-Dohme, Boehringer-Ingelheim and Chiesi; A. Janssens received non-financial support from Hoffman-La Roche; B. Colinet received personal fees and non-financial support from Bristol-Myers-Squibb, Hoffman-La Roche, Merck-Sharp-Dohme, Pfizer, Boehringer-Ingelheim and Bayer.
: The study was performed in accordance with the Declaration of Helsinki, Good Clinical Practice and Good Pharmacoepidemiology Practice guidelines and laws and regulations governing medical practice in Belgium. The study protocol and other study-related documents were submitted or notified to each center’s ethics committee. Approval was granted by each ethics committee.
: Depending on the centers’ ethics committees’ requirements, patients either signed an informed consent form, received an information letter with the opportunity to object to the use of their medical information or were not specifically informed about the use of their medical records for this study.
: The datasets used in the current study are available from the corresponding author on reasonable request.
: Not applicable.